Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Medical and social characteristics of persons with adverse cardiometabolic risk profile

Cover Page

Abstract


The study evaluated the effectiveness of screening tests performed on the basis of functioning centers of Health, to identify individuals with cardiometabolic risk factors. Materials and methods: A total of 2007 men (mean age 50,80±16,54 years) were evaluated. The results of physical and psychological tests, express-analysis of functional state of heart via ECG, express-analysis of cholesterol and glucose blood levels, vascular screening, and concentration of carbon monoxide, carboxyhemoglobin and human body composition by bioimpedance were estimated. Results: During the screening we revealed 62.33% men with BMI≥25 kg/m2. BMI≥25 kg/m2 was associated with an increase in the average levels of cholesterol, fasting blood glucose, blood pressure, as well as signs of myocardial electrical instability and autonomic dysfunction. Progressive increase in BMI≥25 kg/m2 was associated with the presence of combined cardiometabolic risk factors and the presence of unhealthy lifestyle behaviors. All patients with a BMI≥25 kg/m2 received individual recommendations about a mode of work, physical activity and diet, and were also invited for group training in «Weight reduction school»

  1. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ 2001;9(2):56–60.
  2. Михайлов В.М. Вариабельность ритма сердца: опыт практического применения. Иваново, 2002. 288 с.
  3. Моисеев С.В., Фомин В.В. Симпатическая нервная система и метаболический синдром. Клиническая фармакология и терапия 2004;4:70–74.
  4. Шугушев Х.Х., Василенко В.М., Балаева Т.Б. Нарушения ритма сердца и электрографические показатели у больных с артериальной гипертонией и метаболическим синдромом. Российский кардиологический журнал 2011;1:40–44.
  5. Cutler J.A., Sorlie P.D., Wolz M., et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008;52:818–827.
  6. Francischetti E.A., Genelhu V.A. Obesity-hypertension: an ongoing pandemic. Int. J. Clin. Pract 2007;61:269–280.
  7. Guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol 2010;56(25):2182–2199.
  8. Kawamoto R., Tomita H., Oka Y. et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern. Med 2005;44:1232–1238.
  9. Lloyd-Jones D., Adams R., Carnethon M. et al. American Heart Association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics – 2009 Update. A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation2009;119(3):480–486.
  10. Mancia G., Dell’Oro R., Quarti-Trevano F. et al. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease. J. Hypertens 2006;24:51–56.
  11. Marquez P.V., Dying Too Young. Addressing premature mortality and ill health due to non-communicable diseases and injuries in the Russian Federation (Summary) 2005. The World Bank 1818 H Street NW Washington DC 20433 (USA) 2005. 148 р.
  12. Rahmouni K., Correia M.L.G., Haynes W.G. et al. Obesity-associated hypertension. New insights into mechanisms. Hypertension 2005;45:9–14.
  13. Somers V.K., Dyken M.E., Clary M.P. et al. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest 1995;96:1897–1904.
  14. Tunstall-Pedoe H., Vanuzzo D., Hobbs M. et al. The WHO MONICA Project. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688–700.
  15. Whitlock G., Lewington S., Sherliker P. et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373(9669):1083–1096.

Views

Abstract - 525

PDF (Russian) - 319

Cited-By



Copyright (c) 2012 Avdeeva M.V., Shcheglov L.V., Grigorieva O.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies